Skip to main content
. 2021 Apr 13;17(6):363–374. doi: 10.1038/s41584-021-00603-4

Table 4.

Clinical features of systemic lupus erythematosus in different African countries

Region Southern Africa East Africa West Africa North Africa
Country South Africa South Africa Kenya Sudan Nigeria Nigeria Tunisia Egypt
Study Wadee et al.(2007)108 Budhoo et al.(2018)103 Genga et al. (2015)104 Elbagir et al.(2020)107 Adelowo et al. (2009)100 Adelowo et al. (2012)a102 Khanfir et al. (2013)106 El Hadidi et al. (2018)105
Demographics
Number of participants 226 408 100 115 66 95 749 1,109
Female-to-male ratio 18.0:1.0 10.3:1.0 32.3:1.0 22:1.0 21.0:1.0 22.7:1.0 9.3:1.0 8.7:1.0
Mean (s.d.) age at presentation (years) 34.0 (12.5) 32.9 (13.7) 36.6 (10.7) 34.9b 33.0b 33.4b 30.7b 29.2 (11.5)
Clinical features (%)
Arthritis 70.4 80.6 90.0 85.5 87.0 NR 87.1 76.7
Mucocutaneous manifestations NR NR 78.0 NR NR NR 81.7 78.1
Malar rash 58.4 49.0 54.0 52.2 21.2 NR 68.7 48.5
Discoid rash 41.5 27.7 22.0 6.1 43.9 NR 11.9 5.4
Photosensitivity 38.9 67.2 44.0 53.0 9.0 NR 67.6 45.6
Oral ulcers 38.5 50.0 36.0 63.5 33.0 NR 23.3 34.5
Haematological manifestations 52.2 74.8 67.0 17.4 47.0c NR 81.0 55.0
Renal manifestations 43.8 39.2 24.0 22.8 50.0 NR 49.5 33.1
Neuropsychiatric manifestations 15.9 15.2 19.0 15.6 50.0 NR 37.0 6.4
Serositis 18.1 19.4 28.0 24.3 25.8 NR 49.7 32.2
Autoantibodies (%)
ANA 99.1 96.8 82.0 96.9 98.5 95.7 98.0 96.9
Anti-dsDNA 55.3 45.3 52.0 35.5 53.8 54.4 77.3 79.3
Anti-Sm 40.7 33.8 NR 32.3 63.6 75.7 44.8 22.5
Anti-RNP NR 59.1 NR 24.7 66.7 81.8 45.5 NR
Anti-Ro NR NR NR 45.2d 46.7 69.7 56.4 20.4
Anti-La NR NR NR 23.7 9.0 15.2 32.5 11.6

ANA, antinuclear antibody; dsDNA, double stranded DNA; NR, not reported; RNP, ribonucleoprotein; s.d., standard deviation. aStudy specifically looking at autoantibodies. bs.d. not reported. cAnaemia only. dAnti-Ro60.